Point-of-care information on antipsychotic plasma levels — the concentration of drug circulating in the patient's blood — will result in improved patient care and safety. Regardless of the accessibility of effectual antipsychotic drugs, the pharmacological supervision of schizophrenia is still challenging. It majorly follows a parabolic path of trial and error method.
Moreover, with scandalously increased rates of poor antipsychotic drug adherence and restricted modes to detect it, medical practitioners are often ambiguous about if an absence of treatment response is due to deprived adherence or exact lack of effect. Moreover, while coming across a patient with unendurable side effects, medical practitioners are uncertain whether to change to alternative drug or simply decrease the dose. This vagueness results in unreasonably elevated rates of gratuitous treatment fluctuations,…
